Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| hepatocyte | 3 studies | 63% ± 24% |
Insufficient scRNA-seq data for expression of GYS2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 4670.08 | 226 / 226 | 31% | 0.98 | 124 / 406 |
| kidney | 99% | 35.02 | 88 / 89 | 0% | 0.00 | 1 / 901 |
| adipose | 94% | 302.84 | 1136 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 93% | 36.67 | 610 / 653 | 0% | 0 | 0 / 605 |
| esophagus | 91% | 274.88 | 1315 / 1445 | 2% | 0.03 | 3 / 183 |
| pancreas | 91% | 42.97 | 300 / 328 | 0% | 0 | 0 / 178 |
| bladder | 90% | 23.10 | 19 / 21 | 0% | 0 | 0 / 504 |
| breast | 81% | 146.24 | 370 / 459 | 0% | 0 | 0 / 1118 |
| brain | 75% | 17.52 | 1981 / 2642 | 0% | 0 | 0 / 705 |
| lung | 72% | 14.33 | 419 / 578 | 0% | 0 | 0 / 1155 |
| heart | 72% | 17.03 | 617 / 861 | 0% | 0 | 0 / 0 |
| uterus | 71% | 26.68 | 121 / 170 | 0% | 0 | 0 / 459 |
| intestine | 69% | 19.00 | 665 / 966 | 0% | 0.00 | 2 / 527 |
| blood vessel | 67% | 17.12 | 898 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 64% | 12.00 | 115 / 180 | 0% | 0 | 0 / 430 |
| prostate | 62% | 11.39 | 151 / 245 | 0% | 0 | 0 / 502 |
| spleen | 60% | 15.07 | 144 / 241 | 0% | 0 | 0 / 0 |
| stomach | 54% | 15.70 | 194 / 359 | 0% | 0 | 0 / 286 |
| adrenal gland | 47% | 8.66 | 120 / 258 | 0% | 0 | 0 / 230 |
| muscle | 33% | 6.02 | 264 / 803 | 0% | 0 | 0 / 0 |
| skin | 22% | 5.30 | 393 / 1809 | 0% | 0 | 0 / 472 |
| peripheral blood | 14% | 2.90 | 131 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005978 | Biological process | glycogen biosynthetic process |
| GO_0009749 | Biological process | response to glucose |
| GO_0005856 | Cellular component | cytoskeleton |
| GO_0005829 | Cellular component | cytosol |
| GO_0005938 | Cellular component | cell cortex |
| GO_0030864 | Cellular component | cortical actin cytoskeleton |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0061547 | Molecular function | glycogen synthase activity, transferring glucose-1-phosphate |
| GO_0004373 | Molecular function | glycogen (starch) synthase activity |
| Gene name | GYS2 |
| Protein name | Glycogen [starch] synthase, liver (EC 2.4.1.11) (Glycogen synthase 2) |
| Synonyms | |
| Description | FUNCTION: Glycogen synthase participates in the glycogen biosynthetic process along with glycogenin and glycogen branching enzyme. Extends the primer composed of a few glucose units formed by glycogenin by adding new glucose units to it. In this context, glycogen synthase transfers the glycosyl residue from UDP-Glc to the non-reducing end of alpha-1,4-glucan. . |
| Accessions | ENST00000261195.3 P54840 |